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Background: Due to the shortage of donor hearts, the criteria for acceptance have been considerably expanded.
Hearts with regional or global left ventricular dysfunction are excluded from donation, but stress echo might be
useful to identify patients with reversible wall motion abnormalities, potentially eligible for donation.
Methods: Six marginal candidate donors (mean age, 40 ± 13 years; three men) were enrolled. Resting
echocardiography showed in all subjects a LV ejection fraction ≥ 45% (mean 51 ± 5%), but multiple risk factors
were present. All donors had either global or discrete wall motion abnormalities: Wall Motion Score Index (WMSI)
rest = 1.33 ± 0.25. Stress echocardiography was performed with the dipyridamole high dose of 0.84 mg/kg given
over 6 min.
Results: The stress echo results were abnormal in three donors (WMSI rest = 1.51 ± 0.19 vs peak = 1.41 ± 0.30).
These hearts were excluded from donation and cardiac pathology verification was available in two cases of
confirmed LV myocardial fibrosis and/or severe coronary stenosis. The remaining three hearts improved during
stress (WMSI rest = 1.15 ± 0.13 vs peak = 1.04 ± 0.06) and were transplanted uneventfully. Recipients (three males,
mean age 53 ± 4 years) underwent post-TX coronary angiography, IVUS and endomyocardial biopsies. No recipient
had primary graft failure, and all showed normal coronary angiography and normal LV function (EF = 57 ± 6%;
WMSI = 1 ± 0) at 1-month post-TX. The recipients were alive at 12-month median follow-up.
Conclusions: Dipyridamole stress echo performed in brain-dead potential donors with LV resting global or discrete
wall motion abnormalities identifies hearts with severe morphologic abnormalities excluded from donation (with
fixed response during stress echo) from hearts eligible for donation, showing improvement in regional wall motion
during stress (viability response) and normal function and coronary anatomy following transplantation.
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Early graft failureBackground
Brain death is a hostile environment for the donor heart
and undoubtedly contributes to the occurrence of pri-
mary graft failure after HT. Donor heart dysfunction re-
sults from the “catecholamine storm” (hypertension,
tachycardia, and intense vasoconstriction) that produces
an increase in myocardial oxygen demand and poten-
tially myocardial ischemia. These phenomena may me-
diate myofibrillar degeneration, a process characterized* Correspondence: bombardini@ifc.cnr.it
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distribution, and reproduction in any mediumby injury and death of myofibers in a hypercontracted
state [1]. Myocardial injury interacts with other factors,
increasing the probability of post-operative primary
graft dysfunction [2]. Donor risk factors known to be
associated with early graft failure include higher doses
of inotropic support and longer ischemic time, depressed
systolic function (especially discreet wall motion abnor-
malities), and older donor age [3].
As far as function is concerned, a donor heart should
not be used in the presence of intractable ventricular
arrhythmias, the need for excessive inotropic support,
discreet wall motion abnormalities on echocardiographyntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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with inotropic support [2]. Given that a single echocar-
diographic assessment may be inaccurate or may fail to
predict long-term ventricular contractile function, failure
to use a donor heart because of the initial ejection frac-
tion alone is not justified. Hemodynamic and metabolic
management should be performed before the organ is
declined, when donor left ventricular dysfunction is
present [4,5]. Recent studies have shown that pharmaco-
logical stress echo is feasible for recruiting older donor
hearts that were excluded simply because of the age
limit in patients with normal resting function [6,7].
Pharmacological stress echo might be a feasible technique
in intensive care units, to distinguish between hearts with
reversible (eligible for transplant) vs non-reversible left
ventricular segmental wall motion abnormalities. A prac-
tical advantage is the 2011 Italian National Institute of
Health approval of echo stress methodology for heart
donor selection in Italy with a second-opinion telemedi-
cine system from the core echo lab, IFC, Pisa [8].
Aim of this study was to evaluate the usefulness of di-
pyridamole stress echocardiography in selecting for heart
TX hearts with “standard” donor age but with multiple
risk factors for early graft failure and discreet LV wall
motion abnormalities in resting echocardiogram. The
study hypothesis was that hearts with fixed abnormalities
were not eligible as proven at cardio-autoptic verification,
whereas those with reversible abnormalities were poten-
tially eligible for transplantation as shown by subsequent
angiographic evaluation in transplanted hearts.
Methods
Marginal donor recruitment
After legal declaration of brain death, marginal donors
underwent baseline echocardiography for evaluation of
regional wall motion, global ventricular function, and
ventricular mass, according to American Society of
Echocardiography recommendations [9].
Donor selection by stress echocardiographic criteria
Stress echocardiography was performed following the
European Association of Echocardiography and American
Society of Echocardiography [10,11] protocol, using di-
pyridamole (0.84 mg/kg over 6 min). Echocardiographic
images were continuously recorded and intermittently
digitized. Regional wall motion score index was assessed
and graded on a scale from 1 (normal) to 4 (dyskinetic)
in each of the 17 segments at rest and after stress. LV
wall motion score index was calculated by summing the
scores and dividing the sum by 17. By definition, donors
with abnormal stress echocardiographic results had
fixed wall motion abnormalities and/or stress-induced
wall motion abnormalities. We also considered changes
in LV volumes as an index of global dysfunction, andpressure and volume changes as an index of LV elastance
[6,12]. At baseline and peak stress, the projections of
the four chambers and of the two apical chambers were
recorded to obtain LV end-systolic volume using the
biplane Simpson rule [9] to calculate LV elastance (the
ratio of systolic pressure by cuff sphygmomanometry to
LV end-systolic volume) [12]. A decrease in LV elastance
during stress was considered abnormal. In a previous
study, this response was shown to be associated with mod-
erate to severe coronary or myocardial abnormalities on
cardiac autopsy verification [13]. Potential donors with
normal stress echocardiography are considered suitable
donors; recipients follow a routine treatment. We ac-
cepted a priori four stress echocardiographic criteria ex-
cluding a heart from eligibility as a donor: (1) new
regional wall motion abnormalities (regional wall motion
score > 1.0 in at least one segment), (2) abnormal regional
or global LV dysfunction with fixed response to stress; (3)
negative LV elastance variation during stress (stress value
less than resting value), and (4) submaximal stress prema-
turely stopped because of non-diagnostic limiting effects
(e.g., hemodynamic instability or hypotension with a de-
crease > 40 mmHg in systolic or diastolic blood pressure)
before completion of the infusion. Each of the four criteria
had a different rationale and target: a new-onset regional
wall motion abnormality is a highly specific sign of a sig-
nificant epicardial artery stenosis [10,11]; a fixed response
of abnormal regional or global LV function is a specific
sign of an irreversibly damaged heart that will not recover,
due to extensive necrosis or scarring, and is not eligible
for transplant; a lack of hyperkinetic response with no in-
crease in pressure/volume index is a sensitive marker of
underlying cardiomyopathy [6], and a submaximal test
loses diagnostic and prognostic power and falls within a
gray zone unacceptable in the transplantation setting
[10,11]. Eligible organs were considered for transplant-
ation [14]. Hearts that were not eligible underwent patho-
logic examination [13].Transplantation of eligible hearts
Eligible hearts (with normal echocardiographic findings)
were retrieved using a standard technique and preserved
with cold cardioplegic arrest and topical hypothermia.
Primary graft failure after HT was defined as need for
immediate post-HT mechanical circulatory support [3].
The recipients followed routine treatment and follow-up
procedures. They underwent coronary angiography and
intravascular ultrasound at the first month [3]. Focal and
non-circumferential atherosclerosis with 50% stenosis in
proximal segments of at least one coronary vessel was
regarded as native and donor-transmitted coronary ath-
erosclerosis [15]. Endomyocardial biopsies (EMBs) were
taken for post-transplant rejection status surveillance.
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event was monitored.Anatomic-pathologic study of non-transplanted hearts
Hearts deemed unsuitable as a result of stress echocar-
diographic results were removed from donors and sent
to the Pathology Department Center for a very detailed
macroscopic and microscopic study [13]. Autopsies
were performed by an experienced cardiac pathologist.
Coronary atherosclerosis was graded as absent, subcrit-
ical, or significant. In accordance with the criteria of
cardiac catheterization given above, significant athero-
sclerosis was defined as focal and non-circumferential
atherosclerosis with 50% stenosis in proximal segments
of at least one coronary vessel.Statistical analysis
SPSS version 11 for Windows (SPSS, Inc., Chicago, IL,
USA) was used for statistical analyses. The statistical
analyses included descriptive statistics (frequencies and
percentages for categorical variables and mean ± standard
deviation for continuous variables). P values < .05 were
considered statistically significant.Results
Six marginal candidate donors (mean age, 40 ± 13 years;
three men) were enrolled (Table 1). The causes of death
were head trauma in two, cerebral vascular accident in
three, and cardiac arrest in one. Resting echocardiog-
raphy showed in all a LVEF ≥ 45%, mean value = 51 ±
5%, but multiple risk factors were present: all were heavy
smokers, three had elevated cardiac markers, three had
central venous pressure > 12 mmHg, three had need for
excessive inotropic support, all six had either global or
discrete wall motion abnormalities, with WMSI at rest =
1.33 ± 0.25. Stress echocardiography was performed with
high-dose dipyridamole (0.84 mg/kg over 6 min).Abnormal stress echo response with fixed or worsening
wall motion
The stress echo results were abnormal in three donors:
WMSI peak = 1.41 ± 0.30, with a flat-negative contract-
ile reserve (Figures 1 and 2) (Additional files 1 and 2).
At autopsy study (available in two), the donor with in-
complete recovery of apical hypokinesia showed myocar-
dial fibrosis with a mild DCM aspect (Table 1, donor #1);
the donor with worsening of apical akinesia (Table 1,
donor #3) showed a 90% LAD stenosis, multiple foci of
coagulative necrosis associated with diffuse coagulative
subendocardial myocytolysis (Figure 3).Normal stress echo response with improvement in wall
motion
The remaining three hearts showed reversible left ven-
tricular resting abnormalities (Figures 4, 5, 6 and 7)
(Additional files 3, 4 and 5). WMSI rest = 1.15 ± 0.13 vs
peak = 1.04 ± 0.06. All had positive contractile reserve,
with LV elastance increase during stress. These three
hearts were transplanted uneventfully and underwent
standard post TX coronary, angiography, IVUS and
endomyocardial biopsies. The recipients were male, age
53 ± 4 years. No recipient had primary graft failure and
all showed normal coronary vessel at 1-month post-TX
coronary angiography: left ventricular function was
normal at 1 month post-TX (LVEF = 57 ± 6%; WMSI =
1 ± 0). In the EMBs taken for post-transplant rejection
status surveillance, no significant ischemic peritransplant
injury was noted in two recipients (Table 1, donors #4
and #6) (Figure 6). The recipient of the donor heart with
mild left ventricular hypertrophy and reversible septal
hypokinesia (Table 1, donor #5) showed at EMBs mild
peritransplant injury (Figure 8). The recipients were alive
at 12-month median follow-up.
Discussion
Heart transplantation is an established procedure in
end-stage heart failure patients and results in satisfying
long-term results. However, this surgical therapy has
been limited by a severe and incremental donor organ
shortage in the last few years. Therefore, adequate and
optimal utilization of all suitable donor organs is
mandatory for increasing graft availability. Evidence ex-
ists that certain ‘standard’ donor criteria can be signifi-
cantly liberalized to increase the available donor pool by
accepting ‘Marginal Donors’ who would be declined as
potential organ donors under conventional transplant
guidelines. If echocardiography is the initial assessment
investigation, echocardiographically detected left ven-
tricular systolic dysfunction in the absence of a history
of heart disease is the single most common cause for
non-transplantation of an organ [16]. However, ven-
tricular dysfunction may be transient [17], and arbitrary
thresholds of LV function may exclude hearts that could
be resuscitated to transplantable status. Recent studies
have shown that pharmacological stress echo (with
dipyridamole or dobutamine) is a feasible tool for
recruiting older donor hearts for transplant, excluded
on the basis of age. The ability of pharmacologic stress
testing to select these aged donors has been docu-
mented by the pathological findings in refused hearts
[13] and by the clinical, angiographic and prognostic
data in successfully transplanted hearts [6]. The exclu-
sion criterion based on the presence of wall motion ab-
normalities is potentially overcome by the application of
stress echocardiography that may transiently reverse
Table 1 Donor hearts rescued by stress echocardiography
Donor #1 #2 #3 #4 #5 #6
Age (years) 53 32 50 20 45 36
Sex Female Female Female Male Male Male
Medical history








Smoking Yes Yes Yes Yes Yes Yes
Intensive Care Unit
data
Troponin T (μg/L) 0.1 0.01 0.01 15* 152* 1073*
Central Venous
Pressure (mmHg)
16* - 7 - 13* 15*
Length of stay before
death (days)












Apical Akinesia* Mild LVEF
reduction*
Septal Hypokinesia* Lateral inferior
Hypokinesia*
LVEF, rest (%) 51* 46* 55 49* 60 47*
LV mass index (g/m2) 145* 89 112* 89 133* 102




6 6 4* 6 6 6
LVEF, peak (%) 60 56 59 60 75 55
WMSI, peak 1.12* 1.41* 1.71* 1 1 1.11*
Δ WMSI - 0.17 - 0.18 + 0.06* 0 - 0.18 - 0.15
ΔESP/ESVi
(mmHg/mL/m2)
Negative* (- 0.21) Flat* (0.08) Negative* (-1.7) Positive (+0.94) Positive (+1.2) Flat (0)













Age/sex 56/M 48/M 55/M
Disease Ischemic DC Congenital HD HCM
UNOS Status 2 2 2




- LAD focal 0.6 mm LAD










Follow-up months 26 alive 9 alive 12 alive
*Not Normal.
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Figure 2 Donor #3 in Table 1. An example of a stress echocardiogram with fixed abnormalities in a brain-dead potential donor, showing end-
diastolic and end-systolic frames at rest and following stress using Dipyridamole. The test was prematurely stopped at 4 min due to severe
systemic hypotension; WMSI rest = 1.65; WMSI = 1.71 at stop stress [see Additional file 2]. The pressure volume relation was negative with the
ΔESP/ESV value = - 1.7 mmHg/mL/m2. The heart was sent to the pathology department for detailed macroscopic and histology examination.
Figure 1 Donor #2 in Table 1. An example of a stress echocardiogram in a brain-dead potential donor, showing end-diastolic and end-systolic
frames at rest and following stress using Dipyridamole (0.84 mg/kg in 6’) [see Additional file 1]. Left ventricular interventricular septum and apical
wall a-kinesia are shown in parasternal long-axis (panel A) and short-axis (panel B) chamber views. At peak stress an incomplete viability response
is shown. The donor was considered unsuitable for heart donation.
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Figure 4 Donor #6 of Table 1. Two-dimensional transesophageal echocardiogram recorded immediately after “explosive” subarachnoid
hemorrhage accompanied by extreme systolic hypertensive response with systolic blood pressure ≈ 300 mmHg and acute pulmonary edema.
The donor had discrete left ventricular dysfunction with hypokinesia involving the inferior and lateral LV walls [see Additional file 3].
Figure 3 The donor heart unsuitable for transplant of Figure 2. A) Macroscopic aspect of donor heart. B) Fibro-lipidic plaque narrowing
(≈90%) the lumen of left anterior coronary artery (Mallory trichrome stain; original magnification 25x); in the inset, the corresponding macroscopic
sample. C) Focus of myocardial coagulative necrosis (arrow) in the left ventricle (Hematoxylin-Eosin stain; original magnification 200x). D) Subendocardial
coagulative myocytolysis (arrow) in the septal myocardium (Hematoxylin-Eosin stain; original magnification: 400x).
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Figure 6 The donor heart of donor #6 (Table 1) after heart transplant. In the figure, images from the first two endomyocardial biopsies
(EMBs) performed on the 7th (panel A) and 15th (panel B) days after surgery, where regular myocardium is shown. In the EMBs taken for post-
transplant rejection status surveillance, no significant ischemic peritransplant injury was noted, a finding usually seen in biopsies during the first 6
weeks after transplantation.
Figure 5 Donor #6 of Table 1. The same donor as in Figure 4. Two days after the subarachnoid hemorrhage and after brain death, the donor
underwent a transthoracic dipyridamole stress echo (0.84 mg/kg in 6’) [see Additional file 4]. Left ventricular lateral wall hypokinesia and inferior
wall akinesia are shown in 4-chamber (panel A) and 3-chamber (panel B) views at baseline (left panels). At peak stress a viability response is
shown with recovery of lateral and inferior wall motion (right panels). The donor was considered suitable for heart donation and the heart
was transplanted.
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Figure 7 Donor #4 of Table 1. Transthoracic pharmacological stress echo test using dipyridamole (0.84 mg/kg in 6’) in a potential donor with prolonged
(37 min) cardiac arrest at death [see Additional file 5]. The donor had normal response with normal regional wall motion during pharmacological stress echo.
(panel A, 4-chamber views; panel B, 2-chamber views). The pressure/volume relation was positive and the individual was considered a suitable donor.
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hood to recover over time. Such an approach has been
widely demonstrated in large multicenter studies showing
that the transient improvement induced by either a vaso-
dilator or inotropic response was translated into a stable
recovery and a better outcome in stunned or hibernated
hearts [11,18,19]. In a large subset of brain-dead donor
hearts, left ventricular performance is reduced because the
myocardium is regionally stunned or hibernating rather
than irreversibly infarcted or fibrotic. The detection of re-
versible dysfunctional myocardium is clinically relevant, as
regional or global left ventricular function will improve
after transplant. The phenomenon of troponin elevation
and cardiac dysfunction in the donor may be transient,
suggesting altered sarcolemmal integrity rather than
myocyte necrosis [5].
With pharmacological stress, the principle (i.e., the
underlying physiological marker) of the test relies on the
demonstration of residual contractile reserve in a basally
dysfunctional region; improved myocardial thickening of
segments that are dyssynergic in resting conditions is asign of viability, whereas necrotic segments show no
functional improvement. Such reserve can be elicited
through a flow-mediated increase in contractile function
linked to endogenous adenosine accumulation achieved
by intravenous infusion of dipyridamole.
Comparison with previous studies
Left ventricular dysfunction is a common finding in pa-
tients with intracranial pathologies and brain stem death.
In 147 patients with subarachnoid hemorrhage, global or
regional LV dysfunction was found in 30 (20%) patients on
echocardiography. Regional wall motion abnormalities
tended to cover multiple arterial territories and occurred
in the absence of coronary artery disease [20]. This fre-
quency has been confirmed in a retrospective study of 66
patients with brain stem death, 28 (42%) of whom were
found to have global or segmental LV dysfunction that
was not predicted by clinical and electrocardiographic
examination [21]. Secondly, left ventricular dysfunction
documented on echocardiography in heart donors with
BSD does not appear to correspond to any demonstrable
Figure 8 Recipient of donor #5 in Table 1. Ischemic peritransplant injury in the first 4 endomyocardial biopsies (EMBs) taken for post-transplant
rejection status surveillance. A (12th day after surgery): generic interstitial oedema; B (19th day after surgery): a focus of peritransplant injury with
hypereosinophilic cytoplasm myocites (asterisk) or with coagulative myocytolisis (arrow); C (26th day after surgery): necrotic, evanescent
(disappearing) and fragmented myocytes (asterisk); D (36th day after surgery): a focus of resolving peritransplant injury with regional loss of
myocytes, loose substitutive connective tissue/granulation tissue and pigment-laden macrophages.
Bombardini et al. Cardiovascular Ultrasound 2013, 11:27 Page 9 of 11
http://www.cardiovascularultrasound.com/content/11/1/27pathological abnormality at postmortem [22]. Thirdly,
there is clear evidence not only that donor hearts with
mild abnormalities in LV function on rest echocardiog-
raphy can be successfully transplanted but also that donor
hearts with more severe regional wall abnormalities may
improve immediately post-transplant [23]. The stress echo
approach might also be applied to these potential heart
donors with left ventricular wall motion abnormalities,
since viability response during stress echo effectively rec-
ognizes viable tissue with non-fixed response, as opposed
to necrotic response with scar and fixed wall motion
abnormalities following inotropic challenge with either
dobutamine or dipyridamole [24,25].
Conclusion
Left ventricular dysfunction is common in donor hearts
and in several cases does not correspond to a detectable
pathological abnormality. Abnormal regional or global
resting LV dysfunction is a functionally heterogeneous
entity, encompassing patients both unsuitable and suit-
able for donation. The former group shows fixed or
worsening (abnormal) wall motion response during
stress echo, and significant myocardial and/or coronary
alterations at pathology verification. The second group
shows normal (reversible, viability) wall motion response
during stress echo, and absence of myocardial and/orcoronary alterations at angiography verification, and can
be transplanted uneventfully. The promising data obtained
in this proof-of-concept study should now be substan-
tiated in a larger series in order to change current
guidelines ruling out donation on the basis of probably
too-restrictive criteria of global or discreet regional
wall motion abnormalities.
Additional files
Additional files 1: Quad screen DIP stress echo of a potential heart
donor with discrete wall motion abnormalities at rest showing
incomplete improvement in regional wall motion during stress.
Upper panels rest; lower panels peak stress.
Additional files 2: LV apical wall akinesia is shown at baseline (left
upper panel) and 1-min stress (right upper panel). At 3- and 4-min
stress (lower panels) a worsening of LV function is shown accompanied
by hemodynamic instability.
Additional files 3: In both the two-chamber (upper panel) and
short-axis (lower panel) views note the inferior and lateral left
ventricular dysfunction.
Additional files 4: Left ventricular lateral wall hypokinesia and
inferior wall akinesia are shown in 4- and 3-chamber views at
baseline (left and right upper panels). At peak stress a viability
response is shown with recovery of normal lateral and inferior wall
motion (lower panels).
Additional files 5: Quad screen DIP stress echo: global and regional
wall motion is shown in 4- and 2-chamber views at baseline (upper
panels) and at peak stress (lower panels).
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